Remifentanil preconditioning confers cardioprotection via cardiac κ- and δ-opioid receptors

Anesthesiology

Volumn 102, Issue 2, 2005, Pages 371-378

  Zhang, Ye ^a,b   Irwin, Michael G ^a,c   Tak, Ming Wong ^a   Chen, Mai ^a   Cao, Chun Mei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Department of Anaesthesiology ^*  (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 5 HYDROXYDECANOIC ACID; CHELERYTHRINE; CLAMIKALANT; DELTA OPIATE RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; KAPPA OPIATE RECEPTOR; LACTATE DEHYDROGENASE; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE; POTASSIUM CHANNEL; PROTEIN KINASE C; REMIFENTANIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART PROTECTION; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; NARCOTIC ANTAGONISTS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA;

EID: 13244265918     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200502000-00020     Document Type: Article

References (28)

1. Zhang Y, Irwin MG, Wong TM: Remifentanil preconditioning protects against ischemic injury in the intact rat heart. ANESTHESIOLOGY 2004; 101:918-23
2. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C: Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and isoproterenol. Biochim Biophys Acta 1989; 987:69-74
3. Tai KK, Jin WQ, Chan TK, Wong TM: Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol 1991; 23:1297-302
4. Zhang WM, Jin WQ Wong TM: Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 1996; 28:1547-54
5. Krumins SA, Faden AI, Feuerstein G: Opiate binding in rat hearts: Modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun 1985; 127:120-8
6. Wong TM, Lee AY, Tai KK: Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart: An attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 1990; 22:1167-75
7. Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, Capogrossi MC: Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ Res 1992; 70:66-81
8. Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y: Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors. J Mol Cell Cardiol 1997; 29:711-20
9. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ: Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259:712-8
10. Fryer RM, Hsu AK, Nagase H, Gross GJ: Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 2000; 294:451-7
11. Fryer RM, Pratt PF, Hsu AK, Gross GJ: Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296:642-9
12. Fryer RM, Wang Y, Hsu AK, Gross GJ: Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 2001; 280: H1346-53
13. Fryer RM, Pratt PF, Hsu AK, Gross GJ: Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296:642-9
14. Wang GY, Wu S, Pei JM, Yu XC, Wong TM: Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 2001; 280:H384-91
15. Pyle WG, Lester JW, Hofmann PA: Effects of kappa-opioid receptor activation on myocardium. Am J Physiol Heart Circ Physiol 2001; 281:H669-78
16. Cao CM, Xia Q, Tu J, Chen M, Wu S, Wong TM: Cardioprotection of interleukin-2 is mediated via κ-opioid receptors. J Pharmacol Exp Ther 2004; 309:560-7
17. Wu S, Li HY, Wong TM: Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte: Involvement of kappa-opioid receptor. Circ Res 1999; 84:1388-95
18. Chen M, Zhou JJ, Kam KW, Qi JS, Yan WY, Wu S, Wong TM: Roles of KATP channels in delayed cardioprotection and intraceliular Ca(2+) in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H. Br J Pharmacol 2003; 140:750-8
19. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ: Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res 1999; 84:846-51
20. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-4
21. Miki T, Cohen MV, Downey JM: Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998; 186:3-12
22. ATF channels in myocytes. Circulation 2001; 103: 290-5
23. Kato R, Foex P: Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats. Br J Anaesth 2000; 84:608-14
24. McPherson BC, Yao Z: Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. ANESTHESIOLOGY 2001; 94:1082-8
25. ATP channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol 2001; 33:2007-14
26. Liang BT, Gross GJ: Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 1999; 84:1396-400
27. Kato R, Ross S, Foex P: Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 2000; 84:204-14
28. Minto CF, Schnider TW, Shafer SL: Pharmacokinetics and pharmacodynamics of remifentanil: II. Model application. ANESTHESIOLOGY 1997; 86:24-33